Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Holtzman

Showing results (101-110 of 603) with videos related to

Pageof 61
Sort By:
Neuroreport|June 7, 2011
Sleep deprivation differentially affects dopamine receptor subtypes in mouse striatumMiranda M Lim, Jinbin Xu, David M Holtzman, et al.
Neurology|February 28, 2007
Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarkerRandall J Bateman, Guolin Wen, John C Morris, et al.
Neuron|April 21, 2017
Elucidating the Role of TREM2 in Alzheimer's DiseaseJason D Ulrich, Tyler K Ulland, Marco Colonna, et al.
The Journal of Experimental Medicine|October 11, 2022
Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreadingNimansha Jain, Caroline A Lewis, Jason D Ulrich, et al.
Neurology|June 18, 2014
Supply and demand analysis of the current and future US neurology workforceBrad A Racette, David M Holtzman, Timothy M Dall, et al.
Pediatric Research|March 19, 2005
Maternal dietary supplementation with pomegranate juice is neuroprotective in an animal model of neonatal hypoxic-ischemic brain injuryDavid J Loren, Navindra P Seeram, Risa N Schulman, et al.
Journal of Alzheimer'S Disease : JAD|March 25, 2006
The search for antecedent biomarkers of Alzheimer's diseaseAnne M Fagan, Cynthia A Csernansky, John C Morris, et al.
Biochemistry|September 11, 2014
The binding of apolipoprotein E to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregationKanchan Garai, Philip B Verghese, Berevan Baban, et al.
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic miceYong Ji, Bruno Permanne, Einar M. Sigurdsson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 2011
Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalitiesHien T Tran, Frank M LaFerla, David M Holtzman, et al.
Pageof 61

Showing results (101-110 of 603) with videos related to

Sort By:
Pageof 61
Neuroreport|June 7, 2011
Sleep deprivation differentially affects dopamine receptor subtypes in mouse striatumMiranda M Lim, Jinbin Xu, David M Holtzman, et al.
Neurology|February 28, 2007
Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarkerRandall J Bateman, Guolin Wen, John C Morris, et al.
Neuron|April 21, 2017
Elucidating the Role of TREM2 in Alzheimer's DiseaseJason D Ulrich, Tyler K Ulland, Marco Colonna, et al.
The Journal of Experimental Medicine|October 11, 2022
Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreadingNimansha Jain, Caroline A Lewis, Jason D Ulrich, et al.
Neurology|June 18, 2014
Supply and demand analysis of the current and future US neurology workforceBrad A Racette, David M Holtzman, Timothy M Dall, et al.
Pediatric Research|March 19, 2005
Maternal dietary supplementation with pomegranate juice is neuroprotective in an animal model of neonatal hypoxic-ischemic brain injuryDavid J Loren, Navindra P Seeram, Risa N Schulman, et al.
Journal of Alzheimer'S Disease : JAD|March 25, 2006
The search for antecedent biomarkers of Alzheimer's diseaseAnne M Fagan, Cynthia A Csernansky, John C Morris, et al.
Biochemistry|September 11, 2014
The binding of apolipoprotein E to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregationKanchan Garai, Philip B Verghese, Berevan Baban, et al.
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic miceYong Ji, Bruno Permanne, Einar M. Sigurdsson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 2011
Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalitiesHien T Tran, Frank M LaFerla, David M Holtzman, et al.
Pageof 61